These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9733843)

  • 1. Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain.
    Rubin SA; Pletnikov M; Carbone KM
    J Virol; 1998 Oct; 72(10):8037-42. PubMed ID: 9733843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype.
    Rubin SA; Amexis G; Pletnikov M; Li Z; Vanderzanden J; Mauldin J; Sauder C; Malik T; Chumakov K; Carbone KM
    J Virol; 2003 Nov; 77(21):11616-24. PubMed ID: 14557647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence.
    Lemon K; Rima BK; McQuaid S; Allen IV; Duprex WP
    J Virol; 2007 Aug; 81(15):8293-302. PubMed ID: 17475640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mumps virus neurovirulence safety test in Rhesus monkeys: a comparison of mumps virus strains.
    Rubin SA; Snoy PJ; Wright KE; Brown EG; Reeve P; Beeler JA; Carbone KM
    J Infect Dis; 1999 Aug; 180(2):521-5. PubMed ID: 10395874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-specific contributions to mumps virus neurovirulence and neuroattenuation.
    Sauder CJ; Zhang CX; Ngo L; Werner K; Lemon K; Duprex WP; Malik T; Carbone K; Rubin SA
    J Virol; 2011 Jul; 85(14):7059-69. PubMed ID: 21543475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of population diversity on neurovirulence potential of plaque purified L-Zagreb variants.
    Ivancic-Jelecki J; Forcic D; Jagusic M; Kosutic-Gulija T; Mazuran R; Balija ML; Isakov O; Shomron N
    Vaccine; 2016 Apr; 34(20):2383-9. PubMed ID: 27013432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurovirulence of mumps virus: intraspinal inoculation test in marmosets.
    Saika S; Kidokoro M; Aoki A; Ohkawa T
    Biologicals; 2004 Sep; 32(3):147-52. PubMed ID: 15536045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative evaluation of Leningrad-3 mumps vaccine virus neurovirulence in a neonatal rat model].
    Ignat'ev GM; Otrashevskaia EV; Rubin SA
    Vopr Virusol; 2011; 56(4):30-3. PubMed ID: 21899067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study.
    Rubin SA; Afzal MA; Powell CL; Bentley ML; Auda GR; Taffs RE; Carbone KM
    J Infect Dis; 2005 Apr; 191(7):1123-8. PubMed ID: 15747248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity.
    Sauder CJ; Vandenburgh KM; Iskow RC; Malik T; Carbone KM; Rubin SA
    Virology; 2006 Jun; 350(1):48-57. PubMed ID: 16494912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenicity of mumps virus in the marmoset.
    Saika S; Kidokoro M; Ohkawa T; Aoki A; Suzuki K
    J Med Virol; 2002 Jan; 66(1):115-22. PubMed ID: 11748667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monkey neurovirulence test for live mumps vaccine.
    Maximova O; Dragunsky E; Taffs R; Snoy P; Cogan J; Marsden S; Levenbook I
    Biologicals; 1996 Sep; 24(3):223-4. PubMed ID: 8978921
    [No Abstract]   [Full Text] [Related]  

  • 13. Presence of lysine at aa 335 of the hemagglutinin-neuraminidase protein of mumps virus vaccine strain Urabe AM9 is not a requirement for neurovirulence.
    Sauder CJ; Zhang CX; Link MA; Duprex WP; Carbone KM; Rubin SA
    Vaccine; 2009 Sep; 27(42):5822-9. PubMed ID: 19660591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a model to assess mumps virus neurovirulence in neonatal Wistar rats.
    Ruan J; Dong W; Liu Y; Zhang Y; Niu B; Chen Q; Fu Z; Zhu F; An Q; Tian D
    Vaccine; 2022 Oct; 40(44):6397-6403. PubMed ID: 36184403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the neurovirulence test for mumps vaccines.
    Afzal MA; Marsden SA; Hull RM; Pipkin PA; Bentley ML; Minor PD
    Biologicals; 1999 Mar; 27(1):43-9. PubMed ID: 10441402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurovirulence safety testing of mumps vaccines--historical perspective and current status.
    Rubin SA; Afzal MA
    Vaccine; 2011 Apr; 29(16):2850-5. PubMed ID: 21334386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single nucleotide change in the mumps virus F gene affects virus fusogenicity in vitro and virulence in vivo.
    Malik T; Sauder C; Wolbert C; Zhang C; Carbone KM; Rubin S
    J Neurovirol; 2007 Dec; 13(6):513-21. PubMed ID: 18097883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of defective interfering viral particles in only a few passages in Vero cells attenuates mumps virus neurovirulence.
    Šantak M; Markušić M; Balija ML; Kopač SK; Jug R; Örvell C; Tomac J; Forčić D
    Microbes Infect; 2015 Mar; 17(3):228-36. PubMed ID: 25479555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo growth alter the population dynamic and properties of a Jeryl Lynn mumps vaccine.
    Connaughton SM; Wheeler JX; Vitková E; Minor P; Schepelmann S
    Vaccine; 2015 Aug; 33(36):4586-93. PubMed ID: 26187256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on the neurovirulence of different vaccine strains of parotitis virus in monkeys.
    Rozina EE; Hilgenfeldt M
    Acta Virol; 1985 May; 29(3):225-30. PubMed ID: 2864823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.